1
2
Public (NASDAQ: STIM)
Investment in this commercial-stage medical technology company focused on patients who suffer from psychiatric disorders. Its commercial product, the NeuroStar® Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS.
See more: www.neuronetics.com
Private
Executive Chairman and investor in this digital health platform for people with epilepsy company founded by two Johns Hopkins epileptologists.
See more: www.epiwatch.com